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Many environmental chemicals and pesticides have been found to be estrogenic and have been
shown to stimulate the growth ofesrogen receptor-positive (ER-positive) human breast cancer
cells. Sinceitisdifficultto avoidhumanexposuretoenvironmentaletrogens,apotentiallyimpor-
tant area ofresearch is the development ofdietary mategies to prvent the stmulated growth of
breasttumors byenvironmentalestogens. In this context, theinhbitoryactionofc min and a
combination ofcurcumin and isoflavonoids were studied inER-positive human breast cancer cells
(MCF-7 andT47D) andER-negative MDA-MB-231 cells inducedbythepesticideo,p'-DDTand
the environmental pollutants 4-nonylphenol and4-octylphenol. The median inhibitoryconcentra-
tion(IC5,) for curcumin in T47D cells was 10 pM when measured ateither a 48-hr or a 6-day
incubation time. The IC50value for curcumin was within the 8-10 pM range for inhibiting the
growth ofT47D cells induced by a 10-pM concentration each of4-nonylphenol, 4-octylphenol,
and o,p'-DDT. TheIC5, forcurcumin in MCF-7 cells induced by 10pM ofeitheroq/-DDT, 4-
octylphenol, or 4-nonylphenol were 9, 39, and >50 pM, respectively. A mination ofcurcun
and isoflavonoids was able to inhibit the induced growth ofER-positive cells up to 95%. For
MDA-MB-231 cells, theIC50for rcmn was 17pM,whichwas reducedto 11 pM inthepres-
ence of25 pM genistein. Curcumin and genisein induce drastic changes in the morphological
shape ofboth ER-positive and ER-negative cdls. Data preted here indicate that a mixtue of
curcuminandisoflavonoids is the mostpotentinhibitoragainstthegrowthofhuman breasttumor
cells. These datasuggest that combinations ofnatural plant compounds mayhavepreventive and
therapeuticapplicationsagainstthegrowthofbreasttumorsinducedbyenvironmentlestogens.
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Environmental chemicals may be involved
in the etiology of a variety of human can-
cers. The cause for the majority of human
tumors has been attributed to exposure to
environmental carcinogens, pollutants, pes-
ticides, drugs, UV-radiation, and tobacco
products (1). A nutritional deficit or surplus
or the absence ofpreventive micronutrients
in the diet can further increase the suscepti-
bility for developing cancers. In addition,
tumors induced by environmental pollu-
tants may be prevented bydietarystrategies.
It is therefore plausible that an imbalance
between the exposure to cancer-causing
environmental factors and the dietary
intake ofpreventive nutrients facilitates the
initiation and growth oftumors.
The incidence of breast tumors in
women is increasing, and environmental
chemicals have been implicated in part for
this increase (2). In vitro and in vivo data
have shown that endogenous estrogens, such
as estradiol, or environmental estrogens
[e.g., DDT, polychlorinated biphenyls, 4-
nonylphenol (4-NP), 4-octylphenol (4-OP),
and many others] promote mammary car-
cinogenesis (3-5). A majority ofthe human
breast tumor cells express estrogen receptors,
and the growth ofsuch tumors is generally
estrogen dependent. The growth ofestrogen
receptor (ER)-positive tumors can be inhib-
ited by antiestrogens blocking the estrogen
receptor (6,7) or by inhibiting estrogen
production (8).
Since it may not be possible to avoid
human exposure to environmental chemi-
cals, developing nutritional strategies for
prevention and control of breast tumors
induced by environmental estrogens is a
highly relevant concept. In this context,
natural plant-derived foods that modulate
tumor growth also could form a frame-
work for developing safe chemopreventive
drugs. Two such dietary natural plant-
derived products of interest are curcumin
and isoflavonoids.
Curcumin (diferuloylmethane)-the
major constituent ofturmeric (aspice used in
Indian dishes), which is isolated from the rhi-
zomes ofthe Curcuma longa Linn plant-has
shown anticarcinogenic properties in animal
and cell models. It inhibits skin, forestomach,
stomach, and colon tumors in animals (9-14)
and mammary tumorigenesis in rats (15).
The antiproliferative effects ofcurcumin have
recently been demonstrated for human oral
epithelial cells (16). Many other interesting
biological effects ofcurcumin, such as inhibi-
tion ofprotein kinases and tumor promotion
pathways, have been reported (17-22).
Curcumin has also been shown to have anti-
stimulation properties toward human immun-
odeficiency virus (HIV) type I by inhibiting
HIV-1 integrase and protease (23). The anti-
inflamatory and antioxidant properties ofcur-
cumin have been known for a long time (24).
Most ofthe above studies on animal and cell
models suggest curcumin, also found in many
plant products other than turmeric, is an
antiproliferative agent. Its effects on the
growth ofbreast tumor cells are less well stud-
ied, and epidemiological or dinical studies of
the risk for breast cancer in populations con-
suming curcumin in their daily diets have not
beenwelldocumented.
Another class of plant-derived dietary
products, isoflavonoids, have been shown to
have manybeneficial clinical and antitumori-
genic properties (25-24). In addition to the
beneficial properties, in vitro data have indi-
cated that certain dietary compounds such as
genistein and some metabolites of iso-
flavonoids, at concentrations below 10 pM,
can enhance the growth of MCF-7 cells
(28-30). At higher concentrations (>100
PM), isoflavonoids have been shown to cause
nonbeneficial cytotoxicity or sublethal injury
(29). The effect of low or high levels of
isoflavonoids would yield undesirable results.
Considering these limitations, studies ofthe
effect of the combination of curcumin and
isoflavonoids were initiated in our laborato-
ry, where concentrations of individual com-
pounds could be controlled to achieve the
maximum beneficial effects against the
growth ofbreastcells (31).
We previously reported that the combi-
nation of curcumin and genistein is the
most sensitive inhibitor against estrogenic
pesticide-induced growth of ER-positive
MCF-7 human breast cancer cells (31).
Since the inhibitory potency of a single
compound is limited and higher concentra-
tions of inhibitory compounds may cause
toxicity to normal cells or induce sublethal
effects that may cause cellular transforma-
tion or tumor stimulation, the use of a
combination of natural compounds with
different mechanisms ofaction constitutes a
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Figure 1. Effect of curcumin concentration on the
growth of T47D cells. See Materials and Methods
for details. Cell growth was measured after 48 hr
and on day 6 using the tetrazolium (MUT) assay.
Growth of cells in control medium without cur-
cumin was normalized to 100%.
Table 1. Effect of 17p-estradiol, 4-nonylphenol (4-
NP), 4-octylphenol (4-OP), and o,p'-DOT on the
percent proliferation of MCF-7 and T47D cells"
Cells/ Percent
chemical Concentration (pM) proliferation
MCF-7 cells
17p-estradiol 0.005 100
4-NP 5 100
4-OP 5 93
o,p'-DDT 10 93
T47D cells
173-estradiol 0.005 100
4-NP 5 79
4-OP 5 76
o,p'-DDT 10 83
'Calculated induced growth ofMCF-7 and T47D cells by 5 nM 170-
estradiol has been normalized to 100%. The rest ofthe values are
normalized to 100% growth of 17-estradiol. Average values of
three to four separate experiments are presented.
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Figure 2. Effect of curcumin concentration on the
percent growth of MCF-7 cells induced by 4-
nonylphenol (4-NP; 10 pM), 4-octylphenol (4-OP; 10
pM), and o,p'-DDT (10 pM). See Materials and
Methods for details. Cell growth was measured on
day 6 using the tetrazolium (MTT) assay. Induced
cell growth was normalized to 100% in each case.
reasonable approach for preventing the
harmful effects ofenvironmental estrogens.
In this study, the ER-positive (MCF-7
and T47D) and ER-negative (MDA-MB-
231) cell lineswere usedas models forhuman
breast cancer. In this paper, we describe the
inhibitory and cell killing effects ofcurcumin
and curcumin plus isoflavonoids on the
growth of these cells and on the growth of
ER-positive cells induced by the estrogenic
environmental chemicals o,p'-DDT, 4-NP,
and4-OP. These datasupport thecondusion
that a combination of curcumin and
isoflavonoids is the most effective means for
preventing the growth of both ER-positive
andER-negative cells.
Materials and Methods
Chemicals. Stock solutions of o,p'-DDT
from Ultra Scientific, Kinston, Rhode Island;
4-NP and 4-OP from Aldrich Chemical
Company, Milwaukee, Wisconsin; 17-,B
estradiol andcurcuminfrom SigmaChemical
Company, St. Louis, Missouri; and genistein,
daidzein, biochanin A, formononetin, and
equol from Indofine, Sommerville, New
Jersey, were prepared by dissolving the com-
pounds in DMSO. All stock solutions of
compounds were diluted with phenol red-
free tissue culture media supplemented with
5% dextrane-coated charcoal-treated serum
(DCC; Sigma Chemical Co.) and 100
units/ml of penicillin/streptomycin to an
appropriate concentration (test media). The
control media did not contain more than
0.5% DMSO.
Cell culture and growth procedure.
Estrogen receptor-positive MCF-7 and
T47D and ER-negative MDA-MB-231
human breast cancer cells were grown in
phenol red RPMI 1640 media (Gibco
BRL, Grand Island, NY) supplemented
with 5% fetal calf serum (FCS) and 5 ml
10,000 U/ml of penicillin/streptomycin in
an incubator maintained at 5% CO2 95%
air and 100% humidity at 37°C.
Prior to each experiment with MCF-7
and T47D cells, we replaced phenol red
maintenance media with phenol red-free
media for 24 hr. The phenol red-free media
was then replaced with phenol red-free
RPMI 1640 media supplemented with 5%
DCC-stripped bovine serum for 48 hr. Cells
were detached by adding 2-3 ml 2.5%
trypsin solution. After 15 min, cells were
harvested andwashedwith Ca-Mgfreephos-
phate buffered saline (PBS). Washed cells
were suspended in phenol red-free RPMI
1640 media supplemented with 5% DCC
and antibiotics and were gently agitated by
passing up and down in a pipet to get a sin-
gle cell suspension. Cells were counted by a
Coulter Counter. Cells (2-3 x 105/ml) were
plated in a 12-well culture plate (2 ml/well)
andwere allowed to attach for48 hr.
After 48 hr, media was removed and
replaced by test media (prepared as above)
containing the appropriate concentrations
Table 2. The effect ofthe combination of curcumin and isoflavonoids on the growth of MCF-7 cells induced
by4-nonylphenol (4-NP), 4-octylphenol (4-OP), and o,p'-DDT
Chemicals (concentration)
MCF-7 cells
4-NP (10 pM)
4-NP (10 pM) + Cur(10 pM) + Gen (25 pM)
4-NP (10 pM) + Cur(10pM) + Eq (10 pM)
4-NP (10 pM) + Cur(25 pM) + Eq (25 pM)
4-NP(10 pM) + Cur(10 pM) + Gen (15 pM) +
Bio (15 pM) + For(15 pM)
4-NP (10 pM) + TAM (1 pM)
4-NP (10 pM) +TAM (2.5 pM)
4-NP(10 pM) +TAM (10 pM)
4-NP(10 pM) +TAM (2.5 pM) + Cur(10 pM)
4-NP (10 pM) + TAM (2.5 pM) + CUR (50 pM)
4-NP (10 pM) +TAM (2.5 pM) + CUR (75 pM)
4-OP (10 pM)
4-OP (10 pM) + Cur(10 pM) + Gen (50 pM)
4-OP (10 pM) + Cur(50 pM) + Gen (50 pM)
o,p'-DDT(10 pM)
o,p'-DDT(10 pM) + Cur(25 pM) + Bio (25 pM)
o,p'-DDT(10 pM) + Cur(10pM) + Eq (10 pM)
o,p'-DDT(10 pM) + Cur(25 pM) + Eq (25 pM)
o,p -DDT(10 pM) + Cur(25 pM)+ For(25 pM)
T47D cells
o,p'-DDT(10 pM)
Cur(15 pM) + Gen (10 pM)
Cur(15 pM) + Gen (25 pM)
Cur(15 pM) + Gen (50 pM)
Percent proliferation
100
48
62
18
25
81
79
74
47
24
17
100
21
6
100
20
42
11
20
100
14
15
5
Abbreviations: Cur, curcumin; Gen, genistein; Eq, equol; Bio, biochanin A; For, formononetin; Tam, tamoxifen citrate. The
induced cell growth by 10 pM concentrations of 4-NP, 4-OP and o,p'-DDT has been normalized to 100% growth for each
compound.
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of environmental chemicals, curcumin,
and/or isoflavones. Control cells were incu-
bated in phenol red-free media containing
5% DCC and an equivalent amount ofthe
solventwithout the test material. The solvent
concentration did not exceed 1%, and this
concentration does not appreciably alter the
cell growth. The cell growth was estimated
on day 6 using the tetrazolium assay (MTT),
as reported previously (31). The absorbance
at 540 nm was used as a measure ofcell den-
sity of live cells. The percent proliferation
was calculated usingthefollowingequation:
Percent proliferation =
Cell Densitywith Test Compound
X 100
Cell Density ofControl
Estrogen receptor-negative MDA-MB-
231 cells (2 x 105 in eachwell) were plated in
12-well plates and were allowed to attach for
24 hr. We replaced the mediawith the media
containing appropriate concentrations ofcur-
cumin and isoflavones. Cell densities were
estimated on day 4 using the MTT assay.
Growth ofcontrol and treated cellswas calcu-
lated using the above equation, and datawere
normalized to 100%.
In order to see the time-dependent inhi-
bition, cells plated in 12-well plates were
treated with phenol red-free media contain-
ing varying concentrations ofcurcumin for
4 hr. Media containing curcumin was
removed. Afterwashing cells with PBS, cur-
cumin and phenol red-free complete medi-
um was added to each well and cells were
allowed to grow in the incubator for 5 days.
Cell morphology. For morphological
studies, MDA-MB-231 and MCF-7 cells
were plated in tissue culture dishes contain-
ing glass coverslips. After reaching near con-
fluence, cells were treatedwith curcumin and
genistein as mentioned above and were incu-
bated foradditional 48 hr. Treated cells were
washed with PBS, fixed with methanol,
stainedwith Giemsa, andphotographed.
MDA-MB-231 control and curcumin-
treated cells (48 hr) were also stained by
the terminal deoxynucleotidyl transferase-
mediated nick labeling (TUNEL) reaction
for determining apoptosis using the
Boehringer Mannheim kit and kit protocol
(Boehringer Mannheim, Indianapolis, IN).
Cells were permeabilized and stained with
propidium iodide (PI). Apoptotic cells
were quantitated using a Zeiss fluorescence
microscope (Zeiss, Thornwood, NY)
Results
Effect ofCurcumin on the Growth of
T47D Cells
The T47D cells used in these studies
respond to 17p-estradiol (i.e., ER-positive).
The effect of curcumin on the growth of
these cells as a function of the concentra-
tion and time of incubation is shown in
Figure 1. The cell growth in 2% FCS has
been normalized to 100% for data shown
in Figure 1. The cell growth is inhibited as
a function of curcumin concentration
when measured on day 6 while the inhibi-
tion levels offat approximately 40% when
measured after 48 hr (Fig. 1). However, the
concentration of curcumin required to
inhibit the growth of T47D cells by 50%
(IC50) is approximately the same (10 ,uM)
when measured after 48 hr or on day 6.
Effect ofCurcumin on Induced
Proliferation ofER-positive Cells
MCF-7 cells. It has been reported that the
pesticide o,p'-DDT and the environmental
chemicals 4-NP and 4-OP have estrogenic
properties. These compounds can induce
the proliferation of MCF-7 cells (Table 1)
(32). 4-NP was found to be more potent at
inducing growth at the 5 pM concentra-
tion. Higher concentrations (>10 pM) of
4-NP and 4-OP are found to be toxic to
MCF-7 cells.
The effect ofcurcumin on the prolifera-
tion ofMCF-7 cells induced by o,p'-DDT,
4-NP, and 4-OP is shown in Figure 2. For
the sake of calculating the IC50 values for
individual antagonistic compounds, the per-
cent growth ofcells induced by environmen-
tal chemicals has been normalized to 100%.
The curcumin IC50s for inhibition ofgrowth
induced by o,p'-DDT, 4-OP, and 4-NP are
9, 39, and >50 pM, respectively. Curcumin
appears to be a potent inhibitor of o,p'-
DDT-induced cell proliferation and a less
effective inhibitor for 4-NP-induced prolifer-
ation. At 50 pM ofcurcumin, thecell growth
induced by o,p'-DDT is reduced to 12% of
that notedin theabsenceofcurcumin.
Table 2 shows the inhibitory effects of
various combinations of curcumin and
isoflavonoids on the growth ofMCF-7 cells
induced by environmental pollutants. The
induced growth by pollutants has been nor-
malized to 100%. The percent growth in the
presence ofthecombination ofcurcumin and
isoflavonoids was then calculatedwith respect
to this normalized value. Data presented in
Table 2 showasynergistic inhibitory effect in
the presence ofthe combination ofcurcumin
and isoflavonoids. As shown in Table 2, the
4-NP-induced cell growth is reduced to 48%
(52% inhibition) in the presence ofa mixture
ofcurcumin (10 pM) and genistein (25 FM).
A mixture ofcurcumin and equol at 25 pM
each reduces the growth of MCF-7 cells
induced by4-NP and o,p'-DDT to 18% and
11%, respectively. Tamoxifen, a well-studied
antiestrogen can reduce the growth ofMCF-
7 cells induced by 4-NP to 70-80%, while
the mixtures oftamoxifen (2.5 pM) and cur-
cumin (10-75 pM) can substantially reduce
the induced growth (Table 2). The combina-
tion of curcumin and genistein at 50 pM
each is able to reduce the growth ofMCF-7
cells induced by 10 pM 4-OP to 6% (94%
inhibition).
T47Dcells. The done ofT47D cells used
here is estrogen responsive and shows induced
proliferation in the presence of 17p-estradiol.
The growth ofT47D cells in the presence of
5 nM 17p-estradiol was normalized to 100%;
relative normalizedvalues forthe inducedper-
centproliferation by o,p'-DDT, 4-NP, and4-
OP are 83, 79, and 76%, respectively. In
Figure 3, the induced growth by individual
environmental chemicals has been normalized
to 100% and each data point represents the
percent growth inhibition as a function of
curcumin concentration. The IC50 values of
curcumin are within the 8-10 pM range for
inhibiting the induced growth by 10pM con-
centrations of4-NP, 4-OP, and o,p'-DDT.
Unlike the inhibitory effects seen in MCF-7
cells, curcumin seems to be an equally effec-
tive growth inhibitor ofT47D cells in the
presenceofeachofthesegrowthinducers.
The combination of curcumin and
isoflavonoids is more potent in T47D cells
induced by environmental pollutants (Table
1). Curcumin alone, at the concentration of
15 pM, could reduce the growth ofT47D
cells induced by o,p'-DDT (10 pM) to
approximately 35% (Fig. 3), while a mixture
ofcurcumin (15 pM) and genistein (10 and
25 pM) is able to reduce the induced growth
to about 15% (Table 1).
Effect ofCurcumin on the Growth of
ER-negative MDA-MB-231 Cells
Estrogen receptor-negative MDA-MB-231
cells were used to determine whether
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Figure 3. Effect of curcumin concentration on the
percent growth of T47D cells induced by 4-
nonylphenol (4-NP; 10 pM),4-octylphenol (4-OP; 10
pM), and o,p'-DDT (10 pM). See Materials and
Menthnde for details. rail grnowth wasc measured onn
day 6 using the tetrazolium (MTT) assay. Induced
cell growth was normalized to 100% in each case.
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Figure 4. Effect of curcumin (CUR) concentration,
curcumin concentration plus a constant concen-
tration of genistein (GEN; 25 pM), and genistein
concentration plus a constant concentration of
curcumin (10 pM). MDA-MD-231 cells. See
Materials and Methods for details. Cell growth
was measured on day 4 using the tetrazolium
(MTT) assay. The growth of cells in phenol red-
free RPMI 1640 media supplemented with 5% fetal
calf serum was normalized to 100%.
curcumin inhibits cell proliferation by an
estrogen receptor-independent pathway.
Curcumin treatment at concentrations of10,
15, and 25 pM reduced cell growth to 70,
57, and 31%, respectively. Under similar
experimental conditions, genistein (10-50
PM) was not found to inhibit the growth of
MDA-MB-231 cells after treatment for 4 hr.
The cell growth ofMDA-MB-231 cells as a
function ofconcentration ofcurcumin and a
mixture of curcumin and genistein, when
present during the growth period of 5 days,
is shown in Figure 4. Curcumin was found
to be cytotoxic for these cells. The IC50 of
curcumin is 17 pM (Fig. 4). In the presence
of25 pM genistein, the IC50 ofcurcumin is
reduced to 11 pM (Fig. 4). The IC50 value
for genistein in the presence of 10 pM of
curcumin is about 70 pM.
Cell Morphology
Figure 5A and Figure 6A show the normal
shape of MDA-MB-231 and MCF-7 cells,
respectively, growing in culture at 37°C.
When these cells were treated with curcumin
(20 IM) for 48 hr, we observed a profound
change in the shape ofMDA-MB-231 (Fig.
SB) and MCF-7 cells (Fig. 6B). MCF-7 cells
in phenol red-free media and 5% DCC
serum responded to curcumin plus genistein
in asimilar manneras MDA-MB-231 cells in
standard medium treated with curcumin
(data notshown).
The TUNEL labeling for apoptosis
demonstrated that curcumin treatment
increased apoptosis, but the absolute num-
ber was small. Apoptosis data showed a
10% increase in the apoptotic death ofcells
when measured after 48 hr of treatment
with 10 pM ofcurcumin.
Discussion
The data presented in this paper demon-
strate several major points: 1) curcumin
can inhibit the growth of human breast
cancer cells independent of the expression
of estrogen receptors; 2) curcumin more
effectively inhibits the growth ofER-nega-
tive cells in comparison to ER-positive cells
when cells are growing in normal media; 3)
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Figure 5. MDA-MB-231 cells stained with Giemsa. (A) Control. (B) Curcumin treated (20 pM). See Materials and Methodsfor details. Magnification: x600.
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Figure6. MCF-7 cells stained with Giemsa. (A) Control. (B) Curcumin treated (20pM). See Materials and Methodsfordetails. Magnification: x600.
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curcumin can inhibit the growth of both
ER-positive MCF-7 and T47D cells
induced by estrogenic environmental
chemicals and pesticides; 4) the combina-
tion ofcurcumin and genistein is the most
potent inhibitor against the growth ofboth
ER-positive and ER-negative breast cancer
cells; 5) tamoxifen, a well studied antiestro-
gen, could only reduce the growth of
MCF-7 cells induced by 4-NP to about
70-80%, while a combination of tamox-
ifen and curcumin can further reduce the
induced growth; and 6) the inhibitory
effects of curcumin and isoflavonoids are
synergistic and may involve separate path-
ways ofaction.
The exact mechanism ofaction of cur-
cumin for inhibiting the growth of tumor
cells induced by estrogenic environmental
chemicals (ER-positive cells) or ER-negative
cells growing in the normal tissue culture
media has not been fully explored. Many
biological and medicinal properties of cur-
cumin are now well recognized. The
inhibitory action of curcumin against the
growth of tumor cells should be associated
with some of its biological properties. The
anti-inflamatory properties of curcumin
have been known for a long time.
Curcumin has been shown to influence the
activities ofenzymes such as cyclooxigenase
(COX), lipoxygenase (LOX), phospholipase
A2 (PLA2), and phospholipase C-gama-1
(PLCgl) (12,13). Several metabolites of
COX and LOX are involved in growth sig-
naling (33-35). Increased activities ofPLA2
and PLCgl have been observed in breast
tumors (36). PLCgl may produce diacyl
glycerol and inositol 1,4,5-triphosphate;
these signaling compounds can stimulate
protein kinase C, which has been implicat-
ed in modulating cell growth. Curcumin
may be inhibiting the growth of both ER-
positive and ER-negative cells by directly
modulating the activities of COX, LOX,
PLA2, and PLCgl enzymes, including the
activity of protein kinase C, as has been
reported in colon tumors (12,13).
Other feasible mechanisms ofaction of
curcumin could involve suppression of the
activities ofprotein kinases, (e.g., kinase C
and tyrosine kinase) (18,20), many types of
transcription factors (such as hydrogen per-
oxide, tumor necrosis factor, NF-KB) (21),
and proto-oncogenes (22,23).
The cell morphology data presented in
this papershow thatcells become round after
48 hr of treatment with curcumin or cur-
cumin plus genistein. These data suggest the
possibility ofadisruption in cell matrixand a
reduction in cytoplasmic contents of cur-
cumin and curcumin plus genistein-treated
cells. These initial structural disruptions
could direct cells to initiate the apoptotic or
programmed cell death process. There is
some indication by TUNEL data (10%
increase in apoptosis) that this process may
actually be triggered. However, more data
are needed for determining the exact mecha-
nism by which curcumin inhibits the
induced growth ofbreast tumor cells.
Genistein is well recognized for its inhi-
bition of various kinds of protein kinases.
There is a possibility that genistein inhibits
cell growth by its direct action on protein
kinases (e.g., protein kinase C, tyrosine
kinase, MAP-kinase). Protein kinases are
involved in the phosphorylation ofestrogen
and progesterone receptors. Phosphorylated
receptors are involved in activating transcrip-
tion factors. Since curcumin and genistein
have been shown to have a synergistic effect
against the growth ofboth ER-positive and
ER-negative cells, the action of these com-
pounds may be through separate pathways.
The concentration and time-dependent
growth inhibition data suggest that curcum-
in and isoflavonoids may not be competing
for the same target in order to block the
growth. The exact mechanism of action of
these compounds remains to beelucidated.
These results support the concept that a
combination of natural chemopreventive
nutrients is more potent than individual
compounds against suppressing the growth
ofbreast tumors induced either by environ-
mental chemicals or other carcinogens
(31). Also, the in vitro data presented in
this paper constitute the framework for fur-
ther studies in animal models and clinical
trials. Data on natural plant compounds
may further be helpful in developing new
therapeutic agents.
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